Cancer Biomarkers

Papers
(The TQCC of Cancer Biomarkers is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-04-01 to 2026-04-01.)
ArticleCitations
RAB27B expression in pancreatic cancer is predictive of poor survival but good response to chemotherapy82
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification76
The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients42
Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery32
Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer28
Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies27
The effect of low-intensity resistance exercise training on Serum tumor biomarkers and quality of life in women with breast cancer: A randomized controlled trial24
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms24
miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway19
Erratum to: Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells15
Identification of TNFRSF1A as a potential biomarker for osteosarcoma15
YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer15
Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma15
Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma15
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients14
US-Japan collaboration: Collaboration across international boundary14
High TCTA expression is an adverse prognostic biomarker in acute myeloid leukemia13
Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma13
Integrative analysis of histone acetyltransferase KAT2A in human cancer13
KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI113
GINS2 promotes the progression of human HNSCC by altering RRM2 expression13
Machine learning identifies a 5-serum cytokine panel for the early detection of chronic atrophy gastritis patients13
Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer13
Identification of candidate biomarkers and prognostic analysis of recurrence in colorectal cancer12
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers12
Assessing the clinical utility of biomarkers using the intervention probability curve (IPC)11
Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its correlation with ETV4 and Cyclin D1 immunohistochemical expression11
Investigating whether exosomal miR-205-5p derived from tongue squamous cell carcinoma cells stimulates the angiogenic activity of HUVECs by targeting AMOT11
CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML11
A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites10
Analysis of clinical significance and molecular characteristics of methionine metabolism and macrophage-related patterns in hepatocellular carcinoma based on machine learning10
A risk model based on signature genes predicts prognosis and associates with tumor immunity, drug sensitivity in breast cancer10
CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer10
From discovery to clinical implementation of a pancreatic blood biomarker, apolipoprotein A2 isoform10
The overexpression of HOXC6 in LUSC and pan-squamous cell carcinomas indicates the coexistence of nuclear division regulatory mechanisms10
SLAMF8 expression and prognostic significance in melanoma: A multi-omics and Mendelian randomization study9
Albumin-bilirubin score predicts trastuzumab resistance in HER2-positive breast cancer9
Expression of serum HMGB1, SAA, and TSGF in patients with colon cancer and the value of prognostic assessment9
Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis9
Machine learning reveals the role of telomerase activation-related genes in the prognosis of neuroblastoma9
TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma9
The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions9
ELAPOR1 suppresses tumor progression in colorectal cancer and indicates favorable prognosis9
EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma9
Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironment9
A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma9
Lower subcutaneous fat index predicts bone metastasis in breast cancer9
Identification of potential core genes at single-cell level contributing to pathogenesis of pancreatic ductal adenocarcinoma through bioinformatics analysis8
The prognostic significance of DDIT4 in endometrial cancer8
Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma8
Prognosis of keratinizing squamous cell carcinoma of the female reproductive system: A retrospective study8
The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer8
Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer8
External validation of CEA and CA125 prediction model for lymph node metastasis in endometrial cancer: A multi-institute cohort study8
A simplified MyProstateScore2.0 for high-grade prostate cancer8
Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma8
Deep learning approaches for breast cancer detection in histopathology images: A review8
The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study7
Retraction to: Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-4297
Retraction to: Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma7
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients7
Retraction to: MicroRNA-1246 inhibits cell invasion and epithelial mesenchymal transition process by targeting CXCR4 in lung cancer cells7
Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma7
Serum CA19-9 as a predictor of incident metabolic syndrome in obese middle-aged and older men: A 9-year cohort study7
Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients7
Comparative proteomic analysis of exhaled breath condensate between lung adenocarcinoma and CT-detected benign pulmonary nodule patients7
The effect of chromosome abnormalities on expression of SnoRNA in radioresistant and radiosensitive cell lines after irradiation7
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice7
Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma7
Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma7
Blood endocan as a biomarker for breast cancer recurrence7
Uncovering the link between human endogenous retroviruses, inflammatory pathways, and gastric cancer development7
Knockdown of MACC1 expression attenuates colorectal cancer cell glucose metabolism by suppressing GLUT4 membrane translocation7
Tumour microbiota activities associated with local recurrence in ER + PR + breast cancer7
Combination detection of IgG- and IgA-related autoantibodies for the early diagnosis of gastric cancer7
The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors6
Retraction to: LINC01638 lncRNA promotes the proliferation, migration and invasion of prostate carcinoma cells by interacting with Notch16
The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma6
PDCD2L overexpression represents an unfavorable prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer6
Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer6
Non-invasive prediction of DCE-MRI radiomics model on CCR5 in breast cancer based on a machine learning algorithm6
Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases6
Subcutaneous fat predicts bone metastasis in breast cancer: A novel multimodality-based deep learning model6
Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial6
The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer6
A new immune-related gene signature predicts the prognosis and immune escape of bladder cancer6
CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women6
TUBB3 (βIII-tubulin) drives gastric cancer progression and poor prognosis by regulating cell cycle and invadopodia formation6
Internalization of extracellular double-stranded DNA as a potential marker of cancer stem cells in Epstein–Barr virus-induced B-cell lymphoma6
Advances in SEMA3F regulation of clinically high-incidence cancers6
Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS)6
Salivary DNA methylation markers for cancer of oral cavity6
CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulation6
RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients5
Hsa_circ_0101308 adjusted by N6-methyladenosine (m 6 A) impacts chemo-resistance in cervical cancer via sponging miR-2245
Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma5
Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type5
A comprehensive analysis of mRNA expression profiles of Esophageal Squamous Cell Carcinoma reveals downregulation of Desmoglein 1 and crucial genomic targets5
EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy5
Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma5
Retraction to: MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor5
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?5
Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid Leukemia5
Diagnostic utility of lipocalin 2 and metalloproteinase 9 levels in early-stage endometrial cancer5
Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases5
miR-370 is better than miR-375 as a non-invasive diagnostic biomarker for pediatric acute myeloid leukemia patients5
A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma5
Clinical significance of “S” isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody5
Comprehensive analysis of negatively correlated miRNA-mRNA regulatory pairs associated with microsatellite instability in colorectal cancer5
Erratum5
Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer5
Prediction for recurrent non-muscle invasive bladder cancer5
Thresholding of prominent biomarkers of breast cancer on overall survival using classification and regression tree5
2.5185589790344